Basics Affimed N.V. Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells. IPO Date: September 12, 2014 Sector: Healthcare Industry: Biotech Market Cap: $11.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.67% Avg Daily Range (30 D): $0.05 | 8.99% Avg Daily Range (90 D): $0.04 | 5.01% Institutional Daily Volume Avg Daily Volume: 1M Avg Daily Volume (30 D): 24.37M Avg Daily Volume (90 D): 8.38M Trade Size Avg Trade Size (Sh.): 263 Avg Trade Size (Sh.) (30 D): 1,111 Avg Trade Size (Sh.) (90 D): 1,078 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.81M Avg Inst. Trade (90 D): $.81M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 40.89K         News Apr 21, 2025 @ 10:30 AM Affimed Announces Receipt of NASDAQ Deficiency Not... Source: N/A Jun 12, 2024 @ 10:30 AM Affimed Reports First Quarter 2024 Financial Resul... Source: Affimed N.V. Jun 11, 2024 @ 9:50 PM Biorestorative Therapies, Inc. (BRTX) Reports Q1 L... Source: Zacks Equity Research Jun 7, 2024 @ 10:02 AM Vanda (VNDA) Surges 24.2%: Is This an Indication o... Source: Zacks Equity Research Jun 5, 2024 @ 10:30 AM Affimed to Report First Quarter 2024 Financial Res... Source: Affimed N.V. Splits Mar 11, 2024:   10:1